Hengrui Pharma Repurchases 10,000 A Shares for ESOP, Outstanding Float Falls 0.0002%

Bulletin Express

06/10

Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma; HKEX: 01276) disclosed on 10 June 2026 that it bought back 10,000 A shares on the Shanghai Stock Exchange for its A-share Employee Stock Ownership Schemes (ESOP).

The repurchase was executed on 10 June 2026 at prices between RMB 46.02 and RMB 46.06 per share, translating into a volume-weighted average cost of RMB 46.04 and a total consideration of RMB 0.46 million.

Following the transaction: • Issued shares in public hands (excluding treasury shares) declined from 6,370.97 million to 6,370.96 million, a reduction of 0.0002%. • Treasury shares rose from 8.03 million to 8.04 million. • Total issued share capital remained unchanged at 6,379.00 million shares, as the repurchased stock is held in treasury and not yet cancelled.

The company confirmed that the repurchase was duly authorised, executed in compliance with all applicable regulations and stock-exchange rules, and that full payment for the shares has been settled.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/1143399343"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1143399343\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1143399343?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-10 17:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1143399343","market":"hk","top_or_hot":-1,"title":"Hengrui Pharma Repurchases 10,000 A Shares for ESOP, Outstanding Float Falls 0.0002%","media":"Bulletin Express","content":"<p>Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma; HKEX: 01276) disclosed on 10 June 2026 that it bought back 10,000 A shares on the Shanghai Stock Exchange for its A-share Employee Stock Ownership Schemes (ESOP).</p>\n<p>The repurchase was executed on 10 June 2026 at prices between RMB 46.02 and RMB 46.06 per share, translating into a volume-weighted average cost of RMB 46.04 and a total consideration of RMB 0.46 million.</p>\n<p>Following the transaction:\n• Issued shares in public hands (excluding treasury shares) declined from 6,370.97 million to 6,370.96 million, a reduction of 0.0002%.  \n• Treasury shares rose from 8.03 million to 8.04 million.  \n• Total issued share capital remained unchanged at 6,379.00 million shares, as the repurchased stock is held in treasury and not yet cancelled.</p>\n<p>The company confirmed that the repurchase was duly authorised, executed in compliance with all applicable regulations and stock-exchange rules, and that full payment for the shares has been settled.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hengrui Pharma Repurchases 10,000 A Shares for ESOP, Outstanding Float Falls 0.0002%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHengrui Pharma Repurchases 10,000 A Shares for ESOP, Outstanding Float Falls 0.0002%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-10 17:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma; HKEX: 01276) disclosed on 10 June 2026 that it bought back 10,000 A shares on the Shanghai Stock Exchange for its A-share Employee Stock Ownership Schemes (ESOP).</p>\n<p>The repurchase was executed on 10 June 2026 at prices between RMB 46.02 and RMB 46.06 per share, translating into a volume-weighted average cost of RMB 46.04 and a total consideration of RMB 0.46 million.</p>\n<p>Following the transaction:\n• Issued shares in public hands (excluding treasury shares) declined from 6,370.97 million to 6,370.96 million, a reduction of 0.0002%.  \n• Treasury shares rose from 8.03 million to 8.04 million.  \n• Total issued share capital remained unchanged at 6,379.00 million shares, as the repurchased stock is held in treasury and not yet cancelled.</p>\n<p>The company confirmed that the repurchase was duly authorised, executed in compliance with all applicable regulations and stock-exchange rules, and that full payment for the shares has been settled.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01276","symbol_name":"恒瑞医药","start_time":0,"source_url":"","article_id":"1143399343","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1143399343","pubTimestamp":1781084569,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma; HKEX: 01276) disclosed on 10 June 2026 that it bought back 10,000 A shares on the Shanghai Stock Exchange for its A-share Employee Stock...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01276":"恒瑞医药"},"translate_title":"恒瑞医药回购1万股A股用于ESOP流通股跌0.0002%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01276":1},"content_text":"Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma; HKEX: 01276) disclosed on 10 June 2026 that it bought back 10,000 A shares on the Shanghai Stock Exchange for its A-share Employee Stock Ownership Schemes (ESOP).\nThe repurchase was executed on 10 June 2026 at prices between RMB 46.02 and RMB 46.06 per share, translating into a volume-weighted average cost of RMB 46.04 and a total consideration of RMB 0.46 million.\nFollowing the transaction:\n• Issued shares in public hands (excluding treasury shares) declined from 6,370.97 million to 6,370.96 million, a reduction of 0.0002%.  \n• Treasury shares rose from 8.03 million to 8.04 million.  \n• Total issued share capital remained unchanged at 6,379.00 million shares, as the repurchased stock is held in treasury and not yet cancelled.\nThe company confirmed that the repurchase was duly authorised, executed in compliance with all applicable regulations and stock-exchange rules, and that full payment for the shares has been settled.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}